Podcast, Other
E71: Russia/Ukraine deep dive: escalation, risk factors, financial fallout, exit ramps and more
- Podcast Context: The "All In" podcast hosts (Jason Calacanis, David Sacks, Chamath Palihapitiya, and David Friedberg) recorded on Friday, March 4th, focusing on the Russian invasion of Ukraine, economic sanctions, and the risk of global escalation.
- Nuclear Facility Incident: A Russian firefight occurred at the largest nuclear power plant in Europe (Zaporizhzhia), which Russian forces appear to have secured; initial reports of a catastrophic fire or radiation leak were later confirmed by the White House as disinformation or exaggerated.
- No-Fly Zone Decision: NATO officially announced it will not impose a no-fly zone over Ukraine, recognizing that enforcing one requires shooting down Russian aircraft, which constitutes a direct declaration of war between NATO and Russia.
- Article 5 Risks: David Sacks identifies the highest risk scenario as a "Franz Ferdinand moment" where a NATO member (e.g., Poland) accidentally engages Russian forces, triggering Article 5 collective defense and dragging the US into the conflict.
- Economic Warfare Definition: Chamath Palihapitiya argues the West is already in an "economic war" with Russia, utilizing financial infrastructure, asset freezes, and supply chain decoupling (e.g., Boeing, Rolls-Royce, energy sectors) as primary weapons.
- Sanctions Scope: The US and allies are beginning a deep decoupling process; the hosts note this is the "beginning of the beginning," with further incremental sanctions on Russian crude expected.
- Market Impact: LUKOIL's market cap was wiped from ~$60B to zero; while Chamath argues the global economy can absorb this equity loss via central bank liquidity, David Friedberg warns of unknown counterparty risks in swaps and derivatives settling at month-end.
- Humanitarian Crisis: Russia and Ukraine combined account for ~25% of global wheat exports; the sanctions and war have cut off supply chains to Egypt and Africa, creating a potential famine risk that the hosts acknowledge lacks a clear strategic solution.
- Inflation vs. Recession: Chamath predicts central banks (Fed, ECB, BoJ, BoC) will print ~$5T to subsidize commodity shocks, arguing this avoids stagflation and leads to recession rather than inflation; David Friedberg counters that the shock to the "dynamical system" of global capital is unprecedented and potentially irreparable.
- Historical Precedent: The hosts reference the 1998 LTCM collapse, arguing the financial system has evolved to "soft-land" shocks, though David Friedberg remains skeptical about the speed of the current asset devaluation.
- Geopolitical Strategy (Realism vs. Idealism):
- David Sacks and John Mearsheimer's views are cited, suggesting the US failed to offer a "golden bridge" for Putin (e.g., guaranteeing no NATO membership) to prevent the war.
- The hosts argue that "regime change" is a dangerous and historically failed goal; the preferred objective is a ceasefire and a negotiated settlement that respects Russia's stated security red lines.
- Chamath suggests the Ukrainian resistance model (Israeli-style total mobilization) serves as a deterrent to future Chinese aggression in Taiwan.
- Multipolarity Shift: The crisis accelerates a shift from a US unipolar world to a multipolar order, risking further alignment between Russia and China under the leadership of Xi Jinping.
- Information Warfare: The hosts critique the "purity spiral" on social media and cable news, noting that both sides (Ukraine/West and Russia) are heavily engaging in propaganda, including fake stories like "Ghost of Kiev" and the snake island soldiers' surrender.
- Tech Breakthrough (CAR-T): The FDA approved new CAR-T therapies for blood cancers with 88-90% remission rates; a breakthrough by A2 Bio allows targeting of solid tumors.
- CAR-T Economics: Current treatment costs are $400k–$450k per dose; however, research suggests costs could drop to <$5,000 with process optimization, potentially expanding use to autoimmune diseases (lupus, MS).
- CRISPR Patent Dispute: The USPTO ruled in favor of MIT/Harvard over UC Berkeley regarding CRISPR-Cas9 patents; Chamath notes that while litigation continues, open-source alternatives (like the one used in his ventures) are proliferating similar to the Linux operating system.
- Podcast Schedule: The All-In Summit is scheduled for May 15–17, featuring poker tournaments, charity events, and speeches; 400 of 600 tickets are allocated.